K-numberK243977
Device nameEMPHASYS Acetabular System
ApplicantDepuy Ireland UC
Product codeLPH
Device classClass II
Decision dateJan 22, 2025
DecisionSubstantially Equivalent
Regulation888.3358
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The EMPHASYS Acetabular System is a total hip replacement prosthesis consisting of porous-coated titanium alloy acetabular shells and polyethylene liners. It is used with compatible DePuy femoral stems and heads to replace damaged hip joints in patients with osteoarthritis, avascular necrosis, traumatic fracture, failed previous hip surgery, or ankylosis. The acetabular cups are indicated for cementless (uncemented) use only.

Technological characteristics

The subject devices include three additional porous-coated titanium alloy acetabular shells in a multi-hole configuration and ten corresponding AOX polyethylene acetabular liners in three configurations (Neutral, +4 Neutral, and ELV). These represent a line extension to the previously cleared EMPHASYS system with additional sizes, maintaining the same materials, geometry, and method of fixation as the predicate.

Test standards cited

ASTM F1820-22 was used to test interconnection strength of shell and liner. The document indicates that worst-case analyses were performed for range of motion, deformation, impingement, unsupported shell fatigue, shell and liner thickness, articular clearance, wear, friction, and MRI safety, though specific test standards for these analyses are not detailed.

Substantial equivalence argument

The EMPHASYS Acetabular System is substantially equivalent because it uses identical materials (porous titanium alloy shells and AOX polyethylene liners), maintains the same intended use and indications, employs the same method of fixation (uncemented), and operates under the same geometric principles as the predicate. Performance testing demonstrated no new worst-case scenarios, and interconnection strength testing confirmed equivalent performance to the predicate devices.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →